Gabapentin can cause urinary retention, though this side effect is uncommon enough that it does not always appear on the drug’s official prescribing label. An analysis of a national adverse drug reaction database found a statistically significant signal linking gabapentin to urinary retention, and flagged it as one of only five drugs in the study where this side effect was missing from the product labeling entirely. The relationship is more nuanced than a simple yes-or-no, because the same drug is sometimes used therapeutically to calm overactive bladders, and in some cases has caused the opposite problem: incontinence.
What Adverse Event Databases Show
The strongest evidence connecting gabapentin to urinary retention comes from pharmacovigilance databases, which collect reports from patients and clinicians about suspected drug side effects. An analysis of a national spontaneous adverse drug reaction reporting database examined reporting patterns for urinary retention across many commonly prescribed drugs. Out of 39 individual medications that showed a statistically significant reporting odds ratio for urinary retention, gabapentin was among five drugs where this problem was not mentioned in the official summary of product characteristics.1PubMed. Drug-induced Urinary Retention: An Analysis of a National Spontaneous Adverse Drug Reaction Reporting Database In other words, the signal was real enough to flag but had not yet been formally recognized by regulators on the label.
A separate pharmacovigilance study looking specifically at anti-seizure medications and bladder symptoms in the FDA’s adverse event reporting system found that gabapentin exhibited a distinct risk profile for severe bladder and urethral symptoms compared to some other anti-seizure drugs.2PubMed. Anti-seizure medications-associated bladder and urethral symptoms: a pharmacovigilance analysis based on the FAERS database A broader pharmacovigilance analysis of FDA reports spanning two decades also investigated drug-induced urinary retention using statistical methods designed to detect disproportionate safety signals.3PubMed. Investigating drug-induced urinary retention: a pharmacovigilance analysis of FDA adverse event reports from 2004 to 2024
These database studies have limitations. They track voluntarily reported events, which means both under-reporting and confounding are real concerns. A person taking gabapentin may also take other medications that contribute to retention, and the report alone cannot prove gabapentin was the sole cause. Still, when multiple independent databases from different countries independently flag the same drug for the same side effect, the pattern becomes harder to dismiss as coincidence.
Why Gabapentin Affects the Bladder
Gabapentin works by binding to a specific subunit on calcium channels in nerve cells, which dials down the release of certain signaling chemicals. This is what makes it useful for nerve pain and seizures: it quiets overactive nerve signals. But the nerves that control your bladder use the same basic signaling machinery. Animal research has shown that gabapentin suppresses the micturition reflex, the chain of nerve signals that tells your bladder it is time to contract and empty.4Journal of Urology. PD9-06 GABAPENTIN SUPPRESSES THE MICTURITION REFLEXES AND VISCERAL PAIN-RELATED VISCEROMOTOR REFLEX IN THE MICE WITH CYCLOPHOSPHAMIDE-INDUCED CYSTITIS
If that reflex gets suppressed too much, you end up with a bladder that does not contract forcefully enough to empty all the way, or that does not send the “time to go” signal at the appropriate volume. The result is retention: urine pools in the bladder, you feel a constant low-grade fullness or discomfort, and your stream may be weak or interrupted. In more subtle cases, you may not feel anything unusual until a large volume has built up.
Gabapentin Before Surgery and Retention Risk
One specific clinical scenario where the link has been studied is perioperative use. Gabapentin is sometimes given before surgery to reduce post-operative pain, particularly for gynecologic procedures. A study looking at women who received gabapentin before midurethral sling placement found that those who took the drug had higher rates of urinary retention afterward. About 26% of women who received gabapentin experienced retention compared to 18% of those who did not. After adjusting for factors like age and operative time, women who had taken gabapentin had roughly 72% higher odds of retention, though the result did not reach conventional statistical significance.5Female Pelvic Medicine & Reconstructive Surgery. Effects of Preoperative Gabapentin on Clinical Outcomes After Outpatient Midurethral Sling Placement
The researchers could not definitively say gabapentin was responsible, given the relatively small sample and the P value of 0.113. But the direction and size of the effect were notable, especially in a surgical context where the bladder is already vulnerable. For patients heading into any procedure that carries its own risk of post-operative retention, gabapentin could stack the odds in the wrong direction. This is a scenario where clinicians and patients should at least be aware of the possibility.
When Retention Shows Up as Incontinence
Here is where gabapentin’s bladder effects get confusing. Some patients on gabapentin develop what seems like the opposite problem: urinary incontinence, or leaking urine involuntarily. But in at least some of these cases, the incontinence is actually overflow incontinence, which is a direct consequence of retention. The bladder fills beyond its capacity because it cannot empty properly, and urine simply spills over.
A case report described a 61-year-old man with cancer who developed overflow incontinence while taking 1,200 mg of gabapentin daily for nerve pain caused by chemotherapy. When he reduced his dose to 600 mg per day on his own, the overflow incontinence resolved, though his foot pain came back.6PubMed. Gabapentin-Induced Overflow Urinary Incontinence: A Case Report and Review of the Literature This case illustrates an important practical point: if you are on gabapentin and start leaking urine, the instinct may be to assume you have a weak bladder. The real problem could be the exact opposite, a bladder that is too full because it cannot empty.
Separately, case reports have documented straightforward urinary incontinence (not overflow type) in patients taking gabapentin, including three patients with neuropathic pain aged 56 to 66. In each case, the incontinence developed within about a week to ten days of starting gabapentin, and it resolved within a few days of stopping the drug.7PubMed Central. Gabapentin-Induced Urinary Incontinence: A Rare Side Effect in Patients with Neuropathic Pain So gabapentin can seemingly push bladder function in either direction, too little activity (retention) or too much (incontinence), depending on the patient and the dose. This unpredictability makes it easy for clinicians to miss the drug as a cause of bladder symptoms, especially when the symptom does not match the expected side-effect profile.
The Paradox of Gabapentin as a Bladder Treatment
Adding another layer of confusion: gabapentin is sometimes prescribed deliberately to treat overactive bladder, particularly in patients whose bladders are overactive due to spinal cord injuries or other neurological conditions. A systematic review examining gabapentin’s role in managing neurogenic overactive bladder found that it can serve as a less invasive option, either alongside standard bladder-calming medications or on its own.8PubMed Central. Role of gabapentin in the management of neurogenic overactive bladders: A systematic review
In children with overactive bladder that had not responded to conventional anticholinergic drugs, adding gabapentin improved continence in about half the patients. Bladder capacity increased substantially, and the intensity of involuntary bladder contractions dropped.9PubMed. Gabapentin: a novel drug as add-on therapy in cases of refractory overactive bladder in children In adults with spinal cord injuries whose overactive bladders had not responded to a combination of two other drug classes, gabapentin add-on therapy produced measurable improvement in about 40% of patients, with decreased involuntary contractions and fewer incontinence episodes.10PubMed Central. Gabapentin add-on therapy for patients with spinal cord injury associated neurogenic overactive detrusors that are unresponsive to combined anticholinergic and beta-3 adrenergic therapy
This is not actually as contradictory as it sounds. The mechanism is consistent: gabapentin damps down bladder nerve signaling. In a bladder that contracts too forcefully and too frequently, that is therapeutic. In a bladder that was already functioning normally, the same dampening effect can push function below the threshold needed for proper emptying. The outcome depends on where the patient’s bladder function sits on the spectrum before gabapentin enters the picture. A hyperactive bladder gets brought closer to normal. A normal bladder may get pushed into underactivity.
Who Faces Higher Risk
Not everyone on gabapentin is equally likely to develop bladder problems. Several factors can tip the balance.
Kidney function matters most. Gabapentin is cleared almost entirely by the kidneys, and when kidney function is reduced, the drug accumulates in the body. Patients with renal insufficiency face increased risk of gabapentin-related toxicity because clearance is impaired.11American Society of Nephrology. Gabapentin Toxicity in Existing and Developing Renal Failure Higher drug levels mean a stronger suppression of nerve signaling throughout the body, including the nerves controlling the bladder. A dose that causes no bladder issues in someone with healthy kidneys may cause retention in someone whose kidneys are clearing the drug more slowly.
Age also plays a role, for overlapping reasons. Older adults tend to have reduced kidney function even when they have not been diagnosed with kidney disease. They are also more likely to take other medications that independently affect the bladder, such as antihistamines, certain blood pressure drugs, or anticholinergics used for conditions like irritable bowel syndrome. Each of these can contribute to retention on its own, and combining them with gabapentin raises the risk further.
People who already have bladder issues, particularly men with enlarged prostates, are starting from a baseline of partial obstruction. Gabapentin’s suppressive effect on bladder nerve signaling can be the extra push that tips partial difficulty into outright retention. Women recovering from pelvic surgery, as the midurethral sling data suggests, may face a similar vulnerability during the healing period.
Recognizing and Managing the Problem
The challenge with gabapentin-induced urinary retention is recognition. Because retention is not prominently listed as a side effect, neither patients nor clinicians may think of gabapentin as a cause when bladder symptoms appear. Symptoms to watch for include a feeling that the bladder is not emptying completely, a weak or interrupted urine stream, straining to urinate, needing to urinate frequently in small amounts, or new-onset leaking (which could be overflow incontinence masquerading as a weak bladder).
If retention is severe enough to cause pain or significant urinary buildup, the standard immediate treatment is catheterization to relieve the pressure, combined with either stopping the drug or lowering the dose.12PubMed. Drug-induced urinary retention: incidence, management and prevention In the overflow incontinence case described earlier, simply halving the dose was enough to resolve the problem. That kind of dose sensitivity suggests the effect is concentration-dependent for at least some patients, which is consistent with the kidney-clearance mechanism: more drug in the blood means stronger bladder suppression.
Timing can also help with diagnosis. In the reported incontinence cases, symptoms appeared within one to two weeks of starting gabapentin and resolved within one to seven days of stopping it.7PubMed Central. Gabapentin-Induced Urinary Incontinence: A Rare Side Effect in Patients with Neuropathic Pain If your bladder symptoms track closely with starting gabapentin or increasing the dose, that temporal relationship is a useful clue. The relatively quick resolution after stopping the drug also means that a supervised trial of discontinuation is often the clearest diagnostic test, though you should work with your prescriber rather than stopping abruptly, since gabapentin needs to be tapered to avoid withdrawal effects.
An Underrecognized Signal in a Widely Prescribed Drug
Gabapentin is prescribed for a remarkably broad range of conditions beyond its original approval for seizures: nerve pain from diabetes and shingles, fibromyalgia, restless legs, post-surgical pain, anxiety, and more. Its reputation as a relatively safe drug with few serious side effects has helped drive widespread use, including extensive off-label prescribing. That safety profile is real in broad strokes, but it can create a blind spot. Uncommon side effects that are not on the label tend to be attributed to other causes, and urinary retention is a prime example.
The pharmacovigilance analysis that flagged gabapentin for retention specifically noted it as one of five drugs where the signal was new, meaning the product labeling did not mention it.1PubMed. Drug-induced Urinary Retention: An Analysis of a National Spontaneous Adverse Drug Reaction Reporting Database The researchers called for further evaluation. Until that evaluation leads to label changes, awareness falls to prescribers and patients. If you are taking gabapentin and develop any change in urinary habits, particularly difficulty emptying, it is worth raising with your doctor. The fix may be as straightforward as adjusting the dose or switching to a different medication for the same condition, but identifying gabapentin as the culprit is the step that gets missed most often.
Other Drugs That Commonly Cause Retention
Gabapentin is far from the most common medication to cause urinary retention. Several drug classes carry a much stronger and better-documented association. Anticholinergic medications, used for conditions ranging from overactive bladder to allergies to Parkinson’s disease, are among the most frequent culprits. Opioid pain medications are another well-known cause, particularly after surgery. Certain antidepressants, especially older tricyclics, can also contribute. Alpha-adrenergic agonists found in some cold and flu medications, antipsychotics, and muscle relaxants round out the list of commonly implicated drug classes.12PubMed. Drug-induced urinary retention: incidence, management and prevention
The practical implication is that people taking gabapentin alongside any of these other drugs are stacking risk. Post-surgical patients given gabapentin plus an opioid for pain control, for instance, face contributions from both drugs. Older adults on an anticholinergic for bladder spasms who are also taking gabapentin for neuropathy could find that the combination produces a problem that neither drug alone would have caused. When evaluating new urinary symptoms in anyone on gabapentin, it is worth reviewing the full medication list rather than focusing on any one drug in isolation.